Neuroscientists visualize neural circuitry at once-unattainable depths
Figure 2: Visualization of fluorescently labeled neurons within a rectangular volume encompassing cells in the cerebral cortex and hippocampus. This image was captured with a specialized lens enabling penetration to a depth of 4 millimeters below the brain surface. Credit: 2011 Atsushi Miyawaki
A recent breakthrough in biological sample preparation by scientists at the RIKEN Brain Science Institute in Wako may give Astro Boys x-ray vision a run for its money. By treating tissue samples with an easy-to-prepare mix of chemicals, Atsushi Miyawaki, Hiroshi Hama and their colleagues can render the brain and other tissues as clear as glass, a reversible transformation that gives researchers an unobstructed view of fluorescently labeled cells residing within1.
For decades, the limits of available technology have thwarted attempts to map the dizzying twists and turns of the brain. Neuroscientists have achieved some success in simpler organisms, such as the worm or fly, by using tiny blades to sequentially peel off ultrathin strips of tissue, which can then be imaged via electron microscopy and reassembled computationally. However, this approach is far too labor-intensive and time-consuming for the reconstruction of a system as complex as the mammalian nervous system.
More recent breakthroughs in optical microscopy technology and a rapidly growing arsenal of multi-colored fluorescent proteins have given researchers potent new tools for brain mapping. By restricting the expression of specific fluorescent labels to particular subsets of cells, one can clearly visualize neural circuits within their natural, three-dimensional context; however, the dense tissue of the brain tends to scatter light, limiting the depth to which such imaging strategies can penetrate.
Several research groups have developed clearing agents that improve the transparency of biological samples, such as benzyl-alcohol/benzyl-benzoate (BABB) and a proprietary solution known as FocusClear, but each suffers important limitations. BABB is an organic solvent that requires dehydration of samples to be cleared, says Miyawaki. He adds that such treatment can greatly diminish overall sample fluorescence, and FocusClear does not clear mouse brain samples [readily]. Accordingly, his teams development of the reagent they call Scale could open new frontiers in mouse brain imaging.
Scale initially emerged from the unexpected, chance observation that membranes composed of the material polyvinylidene fluoride, which normally resemble sheets of white paper, become completely transparent when soaked in a high-concentration urea solution. By tinkering with this solution, Miyawaki and colleagues arrived at ScaleA2, a mixture that achieves the same feat with biological tissues.
ScaleA2 can render a mouse brain essentially transparent within two weeks (Fig. 1). This treatment also causes the tissue to swell as a result of water uptake, but the researchers determined that specimens maintain their overall shape and proportions, suggesting that this expansion does not significantly affect the arrangement of the cellular structures being imaged.
In an initial test of their imaging approach, Miyawaki and colleagues found that cells within ScaleA2-treated samples fully retained their fluorescent labels, while tissues treated with BABB yielded greatly diminished signal. More importantly, the transparency induced by ScaleA2 allowed the researchers to visualize far deeper within the brain than before, even when using standard one-photon microscopic approaches that are typically vulnerable to scattering and background image interference.
Although the imaging depth limit of two-photon excitation fluorescence microscopy is usually around 0.7 millimeters in the brain, we were able to image fluorescent neurons with Scale down to a depth of 2 millimeters below the brain surface, says Miyawaki. By designing a specialized microscope lens, they were able to penetrate still farther, to an unprecedented working distance of 4 millimeters below the brain surface (Fig. 2). The level of detail obtained with ScaleA2 proved sufficient for the researchers to map axonal connections between neurons in the corpus callosum, the bridge between the brains hemispheres, and also allowed them to analyze the interaction between neural stem cells and the vasculature within the developing mouse brain.
Figure 1: After two weeks of treatment with ScaleA2, the mouse brain is transparent enough (left) to be readily traversed by the light from a laser beam (right). Credit: 2011 H. Hama et al.Since not all specimens are created equal, Miyawaki and colleagues also experimented with alternative Scale formulations for specialized imaging applications. One of these, ScaleU2, necessitates longer sample incubation, but results in less tissue expansion so may offer advantages for use with embryonic samples or other fragile tissues. In a preliminary experiment on 13.5-day-old mouse embryos, the researchers used ScaleU2 to visualize regions of active cell division in the diencephalona part of the forebrain.
Importantly, the effects of Scale treatment proved fully reversible, and samples that had recovered from clearing proved indistinguishable from their uncleared counterparts, reaffirming the minimal impact of this treatment on tissue structure.
A clear view of the future
Some researchers have designed especially ambitious strategies for neural circuit mapping, such as the Brainbow mouse developed at Harvard Medical School, which combines large numbers of different fluorescent proteins to turn the mouse brain into a dazzling light show in which virtually every neuron stands out clearly from its neighbors. Miyawaki believes Scale should prove highly complementary to such efforts. All the fluorescent proteins weve tested so far are resistant to high concentrations of urea, and should be usable, he says, and so this approach should be compatible with Brainbow.
His team is already engaged in collaborations to apply Scale to targeted investigations in mice. Although the work described to date has focused on genetically expressed fluorescent markers, this approach should also be compatible with other labeling methodologies. Once such techniques have been developed, Scale should prove effective for working with larger tissue samples obtained from species that are not readily amenable to genetic modification, such as primates.
The biggest limitation seen by Miyawaki at present is the need to work with dead tissue, but he suggests that even this may change. Scale is currently limited to fixed biological samples, he says, but at some point in the future, there may be live Scale.
Provided by RIKEN
- New chemical reagent turns mouse brain transparent Aug 31, 2011 | not rated yet | 0
- Scientists create 3-D models of whole mouse organs (w/ Video) Jun 24, 2010 | not rated yet | 0
- The beginnings of the brain May 13, 2011 | not rated yet | 0
- Stanford group creates miniature self-contained fluorescence microscope Sep 12, 2011 | not rated yet | 0
- Researchers identify molecular program for brain repair following stroke Nov 10, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
22 hours ago From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Neuroscience May 18, 2013 | 5 / 5 (1) | 0 |
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
Neuroscience May 17, 2013 | not rated yet | 0 |
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Neuroscience May 17, 2013 | 3.7 / 5 (3) | 0 |
Neurological disorders can have a devastating impact on the lives of sufferers and their families.
Neuroscience May 17, 2013 | 5 / 5 (1) | 0 |
If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit.
Neuroscience May 16, 2013 | 2 / 5 (2) | 0 |
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
57 minutes ago | not rated yet | 0
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
47 minutes ago | not rated yet | 0
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
37 minutes ago | not rated yet | 0
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
1 hour ago | 4.5 / 5 (2) | 0 |
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
1 hour ago | not rated yet | 0 |
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
15 hours ago | not rated yet | 0 |